- NCT00042094
Study of Reactogenicity, Safety, Immunogenicity, and Pock Lesion Formation of a Cell-Cultured Smallpox Vaccine Compared to Dryvax®
Phase 1Completed - NCT00042133
Socio-economic Status and Age-related Disability in a Biracial Community
Completed - NCT00042224
Electroconvulsive Therapy in Clozapine Refractory Schizophrenia
Phase 1Completed - NCT00042172
Treatment for Early Memory Loss
Phase 4Completed - NCT00042159
Transcranial Magnetic Stimulation (TMS) Treatment for Patients With Persistent Auditory Hallucinations
Not ApplicableCompleted - NCT00042211
Preventing Depression in Patients With Macular Degeneration
Phase 3Completed - NCT00042055
CP-461 for the Treatment of Crohn's Disease
Phase 2Completed - NCT00042068
A Multi-Center Trial to Compare Three Doses of Meloxicam and Placebo in Patients With Rheumatoid Arthritis
Phase 3Completed - NCT00042081
Prevention of Autogenous Vein Graft Failure in Coronary Artery Bypass Procedures
Phase 3Completed - NCT00042003
Phase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Blast Phase Who Are Refractory to Imatinib Mesylate (Gleevec)
Phase 2Completed - NCT00041977
Determine the Effect of Administering Periostat(R) Twice Daily on Patients With Acne Rosacea
Phase 3Completed - NCT00042042
Screening Adolescents for Type 2 Diabetes Mellitus in a Community Clinic
Not ApplicableUnknown - NCT00041990
Phase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Accelerated Phase Who Are Refractory to Imatinib Mesylate (Gleevec)
Phase 2Completed - NCT00042029
Treatment of Patients With Major Depressive Disorder With MK0869 (0869-073)
Phase 3Completed - NCT00042016
Phase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Chronic Phase Who Are Refractory to Imatinib Mesylate (Gleevec)
Phase 2Completed - NCT00041821
Nasal Irritation Study: Individual Factors in Nasal Irritant Sensitivity
Not ApplicableCompleted - NCT00041938
Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial
Phase 3Completed - NCT00041834
Geographic Modeling of Traffic and Asthma Rates
Completed - NCT00041951
Search for Genes Influencing Childhood Absence Epilepsy (CAE) Study
Completed - NCT00041964
A Study of HIV Levels During Pregnancy and After Childbirth
Completed - NCT00041847
Gene-Environment Interaction in Prostate Cancer
Completed - NCT00041925
Prevention of Autogenous Vein Graft Failure in Peripheral Artery Bypass Procedures
Phase 2Completed - NCT00041860
Modulation of Benzene Metabolism by Exposure to Environment
Not ApplicableCompleted - NCT00041782
Outpatient Treatment Of Deep Venous Thrombosis Using Subcutaneous Dalteparin (Fragmin) In Low Risk Cancer Patients
Phase 2Terminated - NCT00041899
Comparison of Blood Levels of Two Formulations of the Selective Hormone Receptor Modulator CDB-2914
Phase 1Completed - NCT00041886
Radiofrequency Ablation of Painful Soft Tissue Neoplasms
Completed - NCT00041795
Neotrofin for Treatment of Chemotherapy-Induced Peripheral Neuropathy
Phase 2Completed - NCT00041808
Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver
Phase 1Completed - NCT00041769
Using Drug Levels in the Blood to Guide Therapy in HIV Infected Patients Taking a Protease Inhibitor
Phase 3Completed - NCT00041743
Treatment of Binge Eating Disorder
Not ApplicableCompleted - NCT00041730
Rituxan Plus FavId (Idiotype Vaccine) for Low-grade Non-Hodgkin's Lymphoma
Phase 2Unknown - NCT00041756
Efficacy and Safety of PG-530742 in the Treatment of Mild to Moderate Knee Osteoarthritis
Phase 2Completed - NCT00041704
The Safety and Efficacy of Intravenous Anidulafungin as a Treatment for Azole-Refractory Mucosal Candidiasis (FRMC)
Phase 2Completed - NCT00041717
Safety and Efficacy of Oral Fampridine-SR for the Treatment of Spasticity Resulting From Spinal Cord Injury
Phase 3Completed - NCT00041639
Safety Study of 90Y-hMN14 to Treat Pancreatic Cancer
Phase 1Completed - NCT00041652
Safety Study of hMN14 to Treat Either Colorectal or Breast Cancer
Phase 1Completed - NCT00041678
Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type
Phase 3Completed - NCT00041691
Safety Study of 90Y-hMN14 to Treat Colorectal Cancer Patients With Limited Residual Disease After Surgery
Phase 1Terminated - NCT00041665
Recombinant Human Keratinocyte Growth Factor to Reduce Oral Mucositis in Hematologic Malignancy Patients Undergoing Peripheral Blood Stem Cell Transplantation After Radiation and High-dose Chemotherapy
Phase 3Completed - NCT00041613
Study to Compare the Overall Survival of Patients Receiving INGN 201 (Study Drug) With Patients Receiving Methotrexate
Phase 3Unknown - NCT00041626
Effectiveness and Safety of INGN 201 in Combination With Chemotherapy Versus Chemotherapy Alone
Phase 3Unknown - NCT00041600
Human Epilepsy Genetics--Neuronal Migration Disorders Study
Recruiting - NCT00041496
Prevention Of Recurrence Of Atrial Fibrillation
Phase 2Completed - NCT00041509
ThromboEmbolism Prevention Efficacy and Safety Trial (TEMPEST)
Phase 2Completed - NCT00041587
Pre-operative IL13-PE38QQR in Patients With Recurrent or Progressive Malignant Glioma
Phase 1Completed - NCT00041548
Inhaled Nitric Oxide in Neonates With Elevated A-a DO2 Gradients Not Requiring Mechanical Ventilation
Phase 1Terminated - NCT00041574
Hospital-Based Program for Treatment of Severe Cardiopulmonary Disease With Inhaled Nitric Oxide
Phase 2Terminated - NCT00041561
Effects of Inhaled Nitric Oxide in the Treatment of Acute Hypoxemic Respiratory Failure (AHRF) in Pediatrics
Phase 3Terminated - NCT00040651
Safety and Value of Self Bone Marrow Transplants Following Chemotherapy in Scleroderma Patients
Phase 1Terminated - NCT00041535
OGT 918-006: A Phase I/II Randomized, Controlled Study of OGT 918 in Patients With Neuronopathic Gaucher Disease
Phase 2Completed - NCT00040664
A Clinical Study Of An Investigational Regimen Including Marketed HIV Drugs In HIV-1 Pediatric Subjects Ages 2-18 Years
Phase 2Completed - NCT00040677
A Study of the Efficacy and Safety of ICA-17043 (With or Without Hydroxyurea) in Patients With Sickle Cell Anemia.
Phase 2Completed - NCT00041470
Navelbine, Taxol, Herceptin and Neupogen in Stage IV Breast Cancer: A Phase I - II Trial
Phase 1Terminated - NCT00041392
Effects of Magnesium on Individuals Undergoing Coronary Artery Bypass Graft Surgery
Phase 2Completed - NCT00041418
Cardiac MR of Subclinical CVD: Impact of Age
Completed - NCT00041457
Epidemiology of Venous Thromboembolism
Completed - NCT00041444
Multi-Ethnic Study of Atherosclerosis (MESA) - Ancillary Eye Study
Completed - NCT00041431
Estrogen, Cytokines and Heart Failure in Women
Not ApplicableCompleted - NCT00041405
Mechanisms of Pro-Thrombosis in Diabetes Mellitus -- Ancillary to BARI 2D
Completed - NCT00040625
ALIMTA (Pemetrexed) Alone or in Combination With Cisplatin for Patients With Malignant Mesothelioma.
Unknown - NCT00040027
Thymosin Plus PEG-Interferon in Non-Cirrhotic Hepatitis C Patients Who Did Not Respond to Interferon or Interferon Plus Ribavirin
Phase 3Completed - NCT00040638
Phase 2 Study of TLK286 Administered Weekly in Advanced Non-Small Cell Lung Cancer
Phase 2Completed - NCT00040599
Safety Study of 90Y-hMN14 to Treat Colorectal Cancer
Phase 1Completed - NCT00040573
Safety and Tolerability Study of 131I-TM-601 to Treat Adult Patients With Recurrent Glioma.
Phase 1Completed - NCT00040586
Phase II Trial of Monoclonal Antibody (J591) in Combination With Low-Dose Subcutaneous Interleukin-2
Phase 2Completed - NCT00040560
Study of 111In-DAC as an Medical Imaging Agent for Lung Cancer and Brain Cancer Consistent With Metastatic Lung Cancer
Phase 1Unknown - NCT00040534
Safety and Tolerability Study of Farnesyl Protein Transferase Inhibitor in Combination With Gemcitabine and Cisplatin in Advanced Cancer (Study P01499)(TERMINATED)
Phase 1Terminated - NCT00040547
Farnesyl Protein Transferase Inhibitor (FPTI) in Combination With Docetaxel in Advanced Solid Tumors (Study P01964)(COMPLETED)
Phase 1Completed - NCT00040495
Study Evaluating Pantoprazole in Peptic Ulcer Hemorrhage
Phase 3Completed - NCT00040469
Bone Marrow Transplant From Related Donor for Patients With High Risk Hemoglobinopathies
Phase 2Terminated - NCT00040521
Study Evaluating rhIL-11 in Active Crohn's Disease
Phase 2Completed - NCT00040456
Oral Magnesium Pidolate, Hemoglobin SC Disease, MG Pidolate
Phase 2Terminated - NCT00040482
High Dose Chemo/Radiotherapy and Hematopoietic Stem Cell Transplant for Patients With Multiple Sclerosis
Phase 2Completed - NCT00040430
Study of 111In-DAC as a Medical Imaging Agent for the Detection of Breast Cancer
Phase 1Unknown - NCT00040443
Efficacy And Safety Of CX516 In Elderly Participants With Mild Cognitive Impairment.
Phase 2Completed - NCT00040378
Prevention of Alzheimer's Disease by Vitamin E and Selenium (PREADVISE)
Completed - NCT00040508
Sirolimus for Focal Segmental Glomerulosclerosis
Phase 2Completed - NCT00040417
Bone Marrow Transplant From Donor Using Less Toxic Conditioning for Patient With High Risk Hemoglobinopathies
Phase 2Terminated - NCT00040391
A Trial of an Investigational Drug for the Prevention of Diarrhea Associated With Irinotecan/5FU/Leucovorin Chemotherapy in Previously Untreated Metastatic Colorectal Cancer
Phase 2Terminated - NCT00040404
Safety and Efficacy Study of CEP-1347 in the Treatment of Parkinson's Disease
Phase 2Terminated - NCT00040352
Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma
Recruiting - NCT00040365
Amifostine to Protect the Rectum During External Beam Radiotherapy for Prostate Cancer
Phase 2Completed - NCT00040339
Hypothermia to Treat Severe Brain Injury
Not ApplicableCompleted - NCT00040326
Early Surgical Intervention to Treat Epilepsy
Phase 3Completed - NCT00040313
Pegaptanib Sodium Compared to Sham Injection in Patients With DME Involving the Center of the Macula
Phase 2Completed - NCT00040300
A 14-Day Study of Racivir When Used in Combination in HIV-Infected Males
Phase 1Completed - NCT00040287
Theory-Based Interventions for Smoking and Obesity (Challenge) Trial
Phase 3Completed - NCT00040274
A Study of DPC 817 in HIV-Infected Males
Phase 1Completed - NCT00040183
OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer.
Phase 3Completed - NCT00040170
Vaccine Study of MVA-MUC1-IL2 in Patients With Prostate Cancer
Phase 2Terminated - NCT00040157
Safety and Antiviral Study of ACH-126, 443 (Beta-L-Fd4C) in the Treatment of Adults With HIV Infection and Modestly Detectable Viral Load.
Phase 2Terminated - NCT00040144
Safety and Antiviral Study of ACH126, 433 (b-L-Fd4C) in Adults With Lamivudine-resistant Chronic Hepatitis B
Phase 2Terminated - NCT00040209
JP-1730 to Treat Parkinson's Disease
Phase 2Completed - NCT00040196
How the Loss of Dopamine and Dopamine-Restoring Medicines Affect Movement Performance
Completed - NCT00040261
Clinical Trial of Memantine for Major Depression
Phase 3Completed - NCT00040248
Daclizumab to Treat Wegener's Granulomatosis
Phase 2Completed - NCT00040222
Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer
Completed - NCT00040235
Magnesium Effects in Apheresis
Phase 3Completed - NCT00040131
Safety and Efficacy Study of IL-10 (Tenovil TM) in the Prevention of Post-ERCP Acute Pancreatitis (Study P02580)(TERMINATED)
Phase 2Terminated - NCT00040105
Zarnestra and Gleevec in Chronic Phase Chronic Myelogenous Leukemia
Phase 1Completed